Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmonary function and sleep-related disorders during cervical intrathecal baclofen administration in spinal cord injury
2021-004994-30Phase 4Active
- Sponsor
- Roessingh
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of baclofen in Muscle spasm and spinal cord injury (SCI), sponsored by Roessingh. Primary endpoint: Treatment safety (pulmonary function and sleep-related breathing). Started Feb 2022; status: active.
02
Drugs
baclofen
03
Conditions
Muscle spasmspinal cord injury (SCI)
Beyond the preview
Go deeper on 2021-004994-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004994-30.